Patents by Inventor Jennifer F. Iaci

Jennifer F. Iaci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a Neuregulin to Treat Peripheral Nerve Injury
    Publication number: 20180311312
    Abstract: Embodiments of the invention are directed to use of neuregulins to prevent or treat peripheral nerve injury, to attenuate, ameliorate or avoid the loss of peripheral nerve function.
    Type: Application
    Filed: July 11, 2018
    Publication date: November 1, 2018
    Inventors: Anthony O. Caggiano, Anthony J. Bella, Jennifer F. Iaci
  • Compositions and methods for promoting neuronal outgrowth
    Patent number: 9956273
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: May 1, 2018
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Elliott A. Gruskin, Jennifer F. Iaci, Andrea M. Vecchione, Sarah J. Kasperbauer, Gargi Roy
  • Compositions and methods for promoting neuronal outgrowth
    Patent number: 9468671
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: October 18, 2016
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Elliott A. Gruskin, Jennifer F. Iaci, Andrea M. Vecchione, Sarah J. Kasperbauer, Gargi Roy
  • COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH
    Publication number: 20160279210
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Application
    Filed: June 10, 2016
    Publication date: September 29, 2016
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Elliott A. GRUSKIN, Jennifer F. IACI, Andrea M. VECCHIONE, Sara J. KASPERBAUER, Gargi ROY
  • METHODS FOR TREATING A STROKE-RELATED SENSORIMOTOR IMPAIRMENT USING AMINOPYRIDINES
    Publication number: 20160067232
    Abstract: Disclosed herein are methods and compositions related to therapeutic use of aminopyridines in patients with a stroke-related impairment, in particular, in patients with a stroke-related sensorimotor impairment.
    Type: Application
    Filed: September 8, 2015
    Publication date: March 10, 2016
    Inventors: Andrew R. Blight, Anthony O. Caggiano, Tom J. Parry, Jennifer F. Iaci
  • METHODS FOR TREATING SENSORIMOTOR IMPAIRMENTS ASSOCIATED WITH CERTAIN TYPES OF STROKE USING AMINOPYRIDINES
    Publication number: 20160058743
    Abstract: Disclosed herein are methods and compositions related to therapeutic use of aminopyridines in patients with stroke-related impairments, in particular, in patients with sensorimotor impairments resulting from certain types of stroke.
    Type: Application
    Filed: April 14, 2014
    Publication date: March 3, 2016
    Applicant: ACORDA THERAPEUTICS, INC.
    Inventors: Andrew R. Blight, Anthony O. Caggiano, Tom J. Parry, Jennifer F. Iaci
  • Use of a Neuregulin to Treat Peripheral Nerve Injury
    Publication number: 20150216936
    Abstract: Embodiments of the invention are directed to use of neuregulins to prevent or treat peripheral nerve injury, to attenuate, ameliorate or avoid the loss of peripheral nerve function.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 6, 2015
    Inventors: Anthony O. Caggiano, Anthony J. Bella, Jennifer F. Iaci
  • Use of a neuregulin to treat peripheral nerve injury
    Patent number: 9078861
    Abstract: Embodiments of the invention are directed to use of neuregulins to prevent or treat peripheral nerve injury, to attenuate, ameliorate or avoid the loss of peripheral nerve function.
    Type: Grant
    Filed: October 14, 2010
    Date of Patent: July 14, 2015
    Assignee: Acorda Therapeutics Inc.
    Inventors: Anthony O. Caggiano, Anthony J. Bella, Jennifer F. Iaci
  • COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH
    Publication number: 20150023942
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Application
    Filed: June 27, 2014
    Publication date: January 22, 2015
    Inventors: Elliott A. Gruskin, Jennifer F. Iaci, Andrea M. Vecchione, Sara J. Kasperbauer, Gargi Roy
  • Compositions and methods for promoting neuronal outgrowth
    Patent number: 8785606
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: July 22, 2014
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Elliott A. Gruskin, Jennifer F. Iaci, Andrea M. Vecchione, Sarah J. Kasperbauer, Gargi Roy
  • COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH
    Publication number: 20120207732
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Application
    Filed: April 20, 2012
    Publication date: August 16, 2012
    Inventors: Elliott A. GRUSKIN, Jennifer F. IACI, A. M. VECCHIONE, Sarah KASPERBAUER, Gargi ROY
  • Compositions and methods for promoting neuronal outgrowth
    Patent number: 8183350
    Abstract: Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration.
    Type: Grant
    Filed: May 5, 2003
    Date of Patent: May 22, 2012
    Assignee: Acorda Therapeutics, Inc.
    Inventors: Elliott A. Gruskin, Jennifer F. Iaci, Andrea M. Vecchione, Sarah J. Kasperbauer, Gargi Roy
  • USE OF A NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY
    Publication number: 20110124561
    Abstract: Embodiments of the invention are directed to use of neuregulins to prevent or treat peripheral nerve injury, to attenuate, ameliorate or avoid the loss of peripheral nerve function.
    Type: Application
    Filed: October 14, 2010
    Publication date: May 26, 2011
    Applicant: ACORDA THERAPEUTICS INC.
    Inventors: ANTHONY O. CAGGIANO, ANTHONY J. BELLA, JENNIFER F. IACI